Tofajak-IN 5mg Tablet
Marketer
Cipla Ltd
Salt Composition
Tofacitinib (5mg)
Overview Tofajak-IN 5mg Tablet
Inflammatory joint conditions such as moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis may be treated with the 5mg Tofajak-IN tablet. This medication alleviates joint pain, tenderness, and swelling by suppressing inflammation and slowing the progression of bone and joint deterioration. Tofajak-IN 5mg may be administered alone or in conjunction with other therapies. These tablets can be ingested with or without food, ideally at the same time daily. Dosage is determined by your medical history and current medications, and should always follow your physician's instructions. Discontinuation should only occur under medical supervision to prevent disease exacerbation. Common side effects include upper respiratory infections, headache, diarrhea, and nasopharyngitis. Less frequent, but potentially serious, adverse events like blood clots and gastrointestinal perforations necessitate immediate medical attention. Consult your doctor regarding any concerns about side effects. Pre-treatment blood work is often required, and initiation is contraindicated in the presence of infection. Prior to commencing treatment, disclose any history of tuberculosis, herpes zoster, hepatic or renal impairment, hepatitis B or C, or pulmonary or venous thromboembolism. Tofajak-IN 5mg can increase susceptibility to infections or worsen existing ones; therefore, minimize contact with individuals suffering from contagious illnesses (e.g., chickenpox, measles, influenza). This medication is unsuitable for individuals under 18 years of age and is contraindicated during pregnancy or breastfeeding unless deemed medically necessary. Regular medical monitoring may be required during treatment.
Primary Ingredients of Tofajak-IN 5mg Tablet
No information provided. Please provide the text you wish to be rephrased.
Uses of Tofajak-IN 5mg Tablet
Managing rheumatoid, psoriatic, and ankylosing spondylitis arthritis, plus ulcerative colitis.
Major Benefits of Tofajak-IN 5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tofajak-IN 5mg tablets can be consumed with or without food, however, consistent daily timing is recommended.
Common Side effects of Tofajak-IN 5mg Tablet:
- Upper respiratory tract infection
- Headache
- Diarrhea
- Nasopharyngitis (inflammation of the throat and nasal passages)
How to use Tofajak-IN 5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Tofajak-IN 5mg Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, although consistent timing is recommended.
How Tofajak-IN 5mg Tablet works:
Tofajak-IN 5mg tablets contain a Janus kinase inhibitor that suppresses Janus kinase enzyme activity. This reduces immune system response and inflammation characteristic of rheumatic conditions and ulcerative colitis.
SAFETY ADVICE
AlcoholSAFE
Ingesting alcohol alongside Tofajak-IN 5mg Tablet poses no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Using Tofajak-IN 5mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the benefits against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Tofajak-IN 5mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Tofajak-IN 5mg Tablets.
KidneyCAUTION
Individuals with severe kidney impairment should exercise caution when using Tofajak-IN 5mg tablets. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Tofajak-IN 5mg tablets cautiously, as dose modification may be necessary. Physician consultation is recommended.
What if you forget to take Tofajak-IN 5mg Tablet :
Should you forget to take your Tofajak-IN 5mg Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Never take a double dose.
Facts to Know About Tofajak-IN 5mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Pyrrolopyrimidine Compound |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
| Actions | JAK inhibitors |
3,018 People bought this recently